One of your browser extensions seems to be blocking the video player from loading. To watch this content, you may need to disable it on this site.
From the show
Reading time
1 min
With the French healthcare system now reimbursing the anti-obesity drugs Wegovy and Mounjaro, we explain what the strict conditions are to benefit from them. We discuss France’s rates of obesity and the areas where they’re highest. Finally, we discuss the common stereotype that French people don’t get fat. While not true, it does contain a sliver of truth when comparing France to other EU nations.
Europa Monitor is a seasoned News Editor with over a decade of experience in journalism. Known for his editorial expertise and commitment to accuracy, Europa Monitor leads teams to deliver high-quality news content.
